Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, 060-0812, Japan.
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, 060-0812, Japan.
Int J Pharm. 2015 Nov 10;495(1):171-178. doi: 10.1016/j.ijpharm.2015.08.044. Epub 2015 Sep 7.
Macrophages are key contributors to various inflammatory diseases. Therefore, the development of an efficient in vivo short interference RNA (siRNA) system that can be delivered to macrophages represents a novel treatment strategy for addressing these disorders. It was recently revealed that peritoneal macrophages (PEMs) are involved in several diseases including ovarian cancer, and are now recognized as a promising drug target. We report herein on the use of pH-sensitive cationic YSK05-MENDs as siRNA carriers and on the impact of both the size of the YSK05-MENDs and their administration routes for the efficient targeting PEMs to achieve a high level of gene silencing activity. The size of the YSK05-MENDs had a dramatic effect on their specificity for PEMs when administered intravenously, but not for intraperitoneal injection. Also, significant gene silencing was achieved by an intraperitoneal administration of the YSK05-MEND at a dose in the single digit μg/kg range. To our knowledge, this is the most efficacious method for siRNA delivery for gene silencing in PEMs in vivo reported to date. These findings enabled us to investigate the complex function of PEMs through several gene silencing simultaneously.
巨噬细胞是多种炎症性疾病的主要贡献者。因此,开发一种有效的体内短干扰 RNA(siRNA)系统,能够递送至巨噬细胞,代表了一种针对这些疾病的新型治疗策略。最近发现,腹腔巨噬细胞(PEMs)参与了多种疾病,包括卵巢癌,现在被认为是一种很有前途的药物靶点。我们在此报告了使用 pH 敏感阳离子 YSK05-MENDs 作为 siRNA 载体,以及 YSK05-MENDs 的大小及其给药途径对有效靶向 PEMs 以实现高水平基因沉默活性的影响。当静脉内给药时,YSK05-MENDs 的大小对其针对 PEMs 的特异性有显著影响,但腹腔内注射时则没有。此外,通过腹腔内给予 YSK05-MEND 的剂量在个位数μg/kg 范围内,即可实现显著的基因沉默。据我们所知,这是迄今为止报道的体内 PEMs 中 siRNA 递送用于基因沉默的最有效方法。这些发现使我们能够通过同时进行几种基因沉默来研究 PEMs 的复杂功能。